Alert detail
LCD L37905: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test — CGS Administrators
Policy ID: LCD-L37905Specialty: PulmonologyAdded: 6/5/2026Effective: 2026-05-28lcd
What changed
Envisia and Veracyte IPF tests covered under Medicare LCD.
Who’s affected: Pulmonology billing teams · Effective: 2026-05-28
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.
Not ready to subscribe?
Get the free weekly reimbursement brief for Pulmonology— the week’s changes and deadlines, delivered to your inbox. No account required.